BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3086849)

  • 1. Acceptance of transcutaneous nitroglycerin patches by patients with angina pectoris.
    Schrader BJ; Bauman JL; Zeller FP; Shanes JG; Rich S
    Pharmacotherapy; 1986; 6(2):83-6. PubMed ID: 3086849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin acceptance of transcutaneous nitroglycerin patches: a prospective study of 33 patients.
    Vaillant L; Biette S; Machet L; Constans T; Monpère C
    Contact Dermatitis; 1990 Sep; 23(3):142-5. PubMed ID: 2126502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of adhesive properties of two transdermal nitroglycerin controlled-release systems.
    Chinoy DA; Breaux PC; Ibrahim F
    Clin Ther; 1985; 8(1):30-4. PubMed ID: 3938681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.
    Thadani U; Hamilton SF; Olson E; Anderson J; Voyles W; Prasad R; Teague SM
    Ann Intern Med; 1986 Oct; 105(4):485-92. PubMed ID: 3092711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative evaluation of two transdermal nitroglycerin delivery systems: Nitro-Dur versus Transderm-Nitro. The Collaborative Investigation Group.
    Clin Ther; 1991; 13(5):545-9. PubMed ID: 1799911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained high-dose nitroglycerin transcutaneous patch therapy in angina pectoris: evidence for attenuation of effect over time.
    Frishman WH; Giles T; Greenberg S; Heiman M; Raffidal L; Soberman J; Laifer L; Nadelmann J; Lazar E; Strom J
    J Clin Pharmacol; 1989 Dec; 29(12):1097-105. PubMed ID: 2515215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic reactions to local glyceryl trinitrate administration.
    Kounis NG; Zavras GM; Papadaki PJ; Soufras GD; Poulos EA; Goudevenos J; Alangoussis A; Antonakopoulos K; Frangides C; Peristeropoulou SA; Koutsojannis C
    Br J Clin Pract; 1996 Dec; 50(8):437-9. PubMed ID: 9039714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe allergic contact dermatitis secondary to nitroglycerin in a transdermal therapeutic system.
    Topaz O; Abraham D
    Ann Allergy; 1987 Nov; 59(5):365-6. PubMed ID: 3120627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two transdermal nitroglycerin systems.
    Godoy C; Greenspahn BR; Kushner MJ; Lahti RE; Levy RA; Reese P; Reynolds GM; Rice SC
    Clin Ther; 1986; 8(6):689-93. PubMed ID: 3098427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
    Parker JD; Parker AB; Farrell B; Parker JO
    Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic contact dermatitis secondary to topical nitroglycerin.
    Sausker WF; Frederick FD
    JAMA; 1978 Apr; 239(17):1743-4. PubMed ID: 416235
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tolerability and efficiency of a new transdermic nitroglycerin patch in outpatients with chronic stable angina. The PATRICH Trial].
    Barrios V; Fernández E; Campuzano R; Peña G;
    Rev Clin Esp; 2002 Jul; 202(7):379-84. PubMed ID: 12139821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic efficacy of low-dose nitroglycerin patches in stable angina pectoris.
    Rezaković DE; Lakatos S; Stalec J; Pavicić L
    Z Kardiol; 1986; 75 Suppl 3():90-5. PubMed ID: 3099489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal nitroglycerin in angina pectoris.
    Abrams J
    Eur Heart J; 1989 May; 10 Suppl A():11-9. PubMed ID: 2501090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved skin adherence and patient acceptance in a new transdermal nitroglycerin delivery system.
    Hougham AJ; Hawkinson RW; Crowley JK; Wilson RR; Glode JE; Hilty RW; Hughes SO; Koeppl CG; Kovaric TR; Wyskoarko NP
    Clin Ther; 1989; 11(1):23-31. PubMed ID: 2497985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of transdermal nitroglycerin efficacy with dosage in different subsets of patients.
    Rezaković DE
    Am J Cardiol; 1988 Mar; 61(9):59E-69E. PubMed ID: 3126637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with a transdermal nitroglycerin system.
    Mahapatra RK; Mahapatra D; Yaden S
    Angiology; 1987 Apr; 38(4):277-86. PubMed ID: 3107441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antianginal efficacy of a new nitroglycerin patch.
    Parker JO
    Eur Heart J; 1989 May; 10 Suppl A():43-9. PubMed ID: 2501094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative acceptance of three transdermal nitroglycerin placebo patches.
    Rayment CM; Kaul AF; Garfield JM
    Am J Hosp Pharm; 1985 Jun; 42(6):1362-5. PubMed ID: 3925770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval.
    Schaer DH; Buff LA; Katz RJ
    Am J Cardiol; 1988 Jan; 61(1):46-50. PubMed ID: 3122549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.